Resverlogix Corp. (TSE:RVX – Get Free Report) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 153,440 shares changing hands.
Resverlogix Stock Performance
The business has a 50-day simple moving average of C$0.06 and a 200 day simple moving average of C$0.06. The firm has a market cap of C$15.23 million, a P/E ratio of -1.10 and a beta of 0.71.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is Forex and How Does it Work?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
